2nd July - Statement From The Whittemore Peterson Institute - Regarding CDC Study

[VillageLife]

official Statement from the WPI.........


http://www.wpinstitute.org/news/docs/XMRV-CDC Statementrevisedawfinalawfinal.pdf

Onwards and up! :Retro smile:

 

[VillageLife]

Whittemore Peterson Institute Statement regarding
Centers for Disease Control XMRV Study

Contrary to the WPI study published in Science in October, 2009, as well as studies done by
others, including the NIH and FDA, Mr. William Switzer of the Centers for Disease Control reported
that his research team was unable to detect XMRV in CFS patient samples. This negative finding is in contrast to the WPI study in which we detected XMRV in 67% of CFS patient samples.

To correctly replicate scientific studies it is imperative that researchers use the same methods
and patient criteria to ensure accurate results. The methodology used by the CDC was not the same as
that used in the WPI study nor was the patient selection criteria. In September 2009, WPI sent the CDC
twenty confirmed positive samples and the appropriate methodology to help them develop a clinically
validated test. However, this team chose not to do this.

Until researchers use clinically validated tests to detect XMRV in patient samples, as WPI
and their collaborators have successfully done, an accurate association of XMRV to any diseased
population cannot be made. For this reason, WPI researchers and many others are currently validating
more sensitive clinical assays to assist federal agencies in their search for the true prevalence of XMRV
in the human population.

WPI will continue its core mission to deliver answers to patients with neuro-immune diseases
by supporting the development of accurate diagnostics and providing effective therapeutics and clinical
care.

 

[maryb]

Says it all really but is anyone listening.

 

[citybug]

The press must be bugging them for response.

 

[JPV]

I see were back to 67% again...

http://www.pugilator.com/science/how-many-of-the-mecfs-patients-are-infected-with-xmrv/

 

[Rivotril]

I see were back to 67% again...

http://www.pugilator.com/science/how-many-of-the-mecfs-patients-are-infected-with-xmrv/

maybe they "use " the 67% number because thats the number that is officially confirmed in a peer reviewed paper. The later 95%+ percentages were found after additional studying but were never published in a scientific magazine. so in a kind of news release to "attack"the CDC thing, maybe they thought it would be better to use just the real scientifically confirmed percentage

 

[Trooper]

In September 2009, WPI sent the CDC twenty confirmed positive samples and the appropriate methodology to help them develop a clinically validated test. However, this team chose not to do this.

This bit made me smile ^^ :Retro smile:

Another well balanced statement from the WPI

 

[omerbasket]

maybe they "use " the 67% number because thats the number that is officially confirmed in a peer reviewed paper. The later 95%+ percentages were found after additional studying but were never published in a scientific magazine. so in a kind of news release to "attack"the CDC thing, maybe they thought it would be better to use just the real scientifically confirmed percentage

I think that this is the exact reason as to why they used this number.

 

[George]

I see were back to 67% again...

http://www.pugilator.com/science/how-many-of-the-mecfs-patients-are-infected-with-xmrv/

Dr. Mikovitz said in one of her interviews (can't remember where) that the supplemental paper was being reviewed for publishing, this was back in March. It annoys the hell out of me that some twenty papers including the WPI's two additional papers are being held up but they publish this pap by the CDC.

Too much work has been done by too many good scientist. With the information out now by journalist that the DHHS has a hand in holding this information back I think the scientist themselves are starting to get a little pissed. I hope this set's off a firestorm.

 

[dannybex]

Yes...

I think that this is the exact reason as to why they used this number.

That's precisely the reason.

"This negative finding is in contrast to the WPI study in which we detected XMRV in 67% of CFS patient samples."

eta: perhaps they could have said "...the WPI study published in the journal Science..." ?

 

[bullybeef]

Maybe they want to save their follow-up study (~97% in ME) for when all the negative papers have shot themselves in the foot?

 

[Daffodil]

the last number i heard was 99% of the patient samples used in the science article have now tested positive.

 

[bullybeef]

Yeah, I have heard that many different figures between 95-99% I thought I'd average it to around 97. We do with the paper to make it definitive.

 

[*GG*]

Please Research World, (this includes you taxpayer funded gov't entities),

Please DO YOUR JOB and help the sick get better! People have lost their lives to this horrible illness, some decades and decades, but some only YEARS! (Sarcasm). Meanwhile more people are becoming ill with this disease and will find that there are NO ANSWERS still after decades worth of "research".

Take this research world! and listen up!!

Until researchers use clinically validated tests to detect XMRV in patient samples, as WPI
and their collaborators have successfully done, an accurate association of XMRV to any diseased
population cannot be made.

For this reason, WPI researchers and many others are currently validating
more sensitive clinical assays to assist federal agencies in their search for the true prevalence of XMRV
in the human population.

Whittemore Peterson Institute Statement regarding
Centers for Disease Control XMRV Study

Contrary to the WPI study published in Science in October, 2009, as well as studies done by
others, including the NIH and FDA, Mr. William Switzer of the Centers for Disease Control reported
that his research team was unable to detect XMRV in CFS patient samples. This negative finding is in contrast to the WPI study in which we detected XMRV in 67% of CFS patient samples.

To correctly replicate scientific studies it is imperative that researchers use the same methods
and patient criteria to ensure accurate results. The methodology used by the CDC was not the same as
that used in the WPI study nor was the patient selection criteria. In September 2009, WPI sent the CDC
twenty confirmed positive samples and the appropriate methodology to help them develop a clinically
validated test. However, this team chose not to do this.

Until researchers use clinically validated tests to detect XMRV in patient samples, as WPI
and their collaborators have successfully done, an accurate association of XMRV to any diseased
population cannot be made. For this reason, WPI researchers and many others are currently validating
more sensitive clinical assays to assist federal agencies in their search for the true prevalence of XMRV
in the human population.

WPI will continue its core mission to deliver answers to patients with neuro-immune diseases
by supporting the development of accurate diagnostics and providing effective therapeutics and clinical
care.